↓ Skip to main content

Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab

Overview of attention for article published in Clinical Cancer Research, October 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
14 news outlets
blogs
1 blog
twitter
26 X users

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab
Published in
Clinical Cancer Research, October 2020
DOI 10.1158/1078-0432.ccr-20-1876
Pubmed ID
Authors

Ashley M. Hopkins, Ganessan Kichenadasse, Christos S. Karapetis, Andrew Rowland, Michael J. Sorich

X Demographics

X Demographics

The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 60 100%

Demographic breakdown

Readers by professional status Count As %
Other 8 13%
Researcher 7 12%
Student > Master 6 10%
Student > Ph. D. Student 5 8%
Student > Bachelor 4 7%
Other 9 15%
Unknown 21 35%
Readers by discipline Count As %
Medicine and Dentistry 15 25%
Pharmacology, Toxicology and Pharmaceutical Science 8 13%
Biochemistry, Genetics and Molecular Biology 5 8%
Unspecified 2 3%
Nursing and Health Professions 2 3%
Other 4 7%
Unknown 24 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 111. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 November 2021.
All research outputs
#356,499
of 24,490,209 outputs
Outputs from Clinical Cancer Research
#174
of 13,027 outputs
Outputs of similar age
#10,595
of 421,174 outputs
Outputs of similar age from Clinical Cancer Research
#5
of 202 outputs
Altmetric has tracked 24,490,209 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,027 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,174 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 202 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.